References
- Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, Xu C, Richter MA, Kahn A, Kish SJ, et al. 2017. Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiatry. 74(8):833–840. doi:https://doi.org/10.1001/jamapsychiatry.2017.1567
- Baganz NL, Blakely RD. 2013. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci. 4(1):48–63. doi:https://doi.org/10.1021/cn300186b
- Bhattacharyya S, Khanna S, Chakrabarty K, Mahadevan A, Christopher R, Shankar SK. 2009. Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Neuropsychopharmacol. 34(12):2489–2496. doi:https://doi.org/10.1038/npp.2009.77
- Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S. 2005. Glutamatergic dysfunction in OCD. Neuropsychopharmacol. 30(9):1735–1740. doi:https://doi.org/10.1038/sj.npp.1300733
- Dubois T, Reynaert C, Jacques D, Lepiece B, Patigny P, Zdanowicz N. 2018. Immunity and psychiatric disorders: variabilities of immunity biomarkers are they specific? Psychiatr Danub. 30(7):447–451.
- Erbay L, Kavuran N, Taşkapan Ç, İnce L, Yoloğlu S, Temelli H, Nal S. 2017. Serum IL-1, IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ levels in drug-free, comorbidity-free obsessive-compulsive disorder patients. Anadolu Psikiyatri Derg. 19:1–162. doi:https://doi.org/10.5455/apd.274680
- Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL. 2012. A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry. 53(6):797–804. doi:https://doi.org/10.1016/j.comppsych.2011.12.007
- Giedd JN, Rapoport JL, Garvey MA, Perlmutter S, Swedo SE. 2000. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry. 157(2):281–283. doi:https://doi.org/10.1176/appi.ajp.157.2.281
- Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. 1989. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 46(11):1006–1011. doi:https://doi.org/10.1001/archpsyc.1989.01810110048007
- Gray SM, Bloch MH. 2012. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr Psychiatry Rep. 14(3):220–228. doi:https://doi.org/10.1007/s11920-012-0272-0
- Guy W. 1976. ECDEU assessment manual for psychopharmacology. Washington (DC): US Department of Health, and Welfare.
- Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62. doi:https://doi.org/10.1136/jnnp.23.1.56
- Kim H, Chen L, Lim G, Sung B, Wang S, McCabe MF, Rusanescu G, Yang L, Tian Y, Mao J. 2012. Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest. 122(8):2940–2954. doi:https://doi.org/10.1172/JCI61884
- Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. 2003. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 9(7):914–920. doi:https://doi.org/10.1038/nm892
- Kronfol Z, Remick DG. 2000. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 157(5):683–694. doi:https://doi.org/10.1176/appi.ajp.157.5.683
- Luo F, Leckman JF, Katsovich L, Findley D, Grantz H, Tucker DM, Lombroso PJ, King RA, Bessen DE. 2004. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics. 113(6):e578–e585. doi:https://doi.org/10.1542/peds.113.6.e578
- Maier W, Buller R, Philipp M, Heuser I. 1988. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 14(1):61–68. doi:https://doi.org/10.1016/0165-0327(88)90072-9
- Marazziti D, Mucci F, Fontenelle LF. 2018. Immune system and obsessive-compulsive disorder. Psychoneuroendocrinology. 93:39–44. doi:https://doi.org/10.1016/j.psyneuen.2018.04.013
- Menezes AMB, Oliveira PD, Wehrmeister FC, Gonçalves H, Assunção MCF, Tovo-Rodrigues L, Ferreira GD, Oliveira IO. 2018. Association between interleukin-6, C-reactive protein and adiponectin with adiposity: Findings from the 1993 pelotas (Brazil) birth cohort at 18 and 22 years. Cytokine. 110:44–51. doi:https://doi.org/10.1016/j.cyto.2018.04.020
- Miller GE, Cole SW. 2012. Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol Psychiatry. 72(1):34–40. doi:https://doi.org/10.1016/j.biopsych.2012.02.034
- Mossner R, Lesch KP. 1998. Role of serotonin in the immune system and in neuroimmune interactions. Brain, Behavior, Immunity. 12(4):249–271. doi:https://doi.org/10.1006/brbi.1998.0532
- Muller N, Ackenheil M. 1998. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 22(1):1–33. doi:https://doi.org/10.1016/S0278-5846(97)00179-6
- Nieman DC, Zwetsloot KA, Meaney MP, Lomiwes DD, Hurst SM, Hurst RD. 2015. Post-exercise skeletal muscle glycogen related to plasma cytokines and muscle IL-6 protein content, but not muscle cytokine mRNA expression. Front Nutr. 2:27.
- Raison CL, Capuron L, Miller AH. 2006. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27(1):24–31. doi:https://doi.org/10.1016/j.it.2005.11.006
- Rao NP, Venkatasubramanian G, Ravi V, Kalmady S, Cherian A, Yc JR. 2015. Plasma cytokine abnormalities in drug-naive, comorbidity-free obsessive-compulsive disorder. Psychiatry Res. 229(3):949–952. doi:https://doi.org/10.1016/j.psychres.2015.07.009
- Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry. 59(20):22–33.